Internal Medicine, Pulmonary Disease · Winter Haven, FL
NPI
1215918420
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
500 E Central Ave
Winter Haven, FL, 33880
Phone (863) 293-1191
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
2,572 services
Medicare patients, 2024
673
Average age 77
Drug cost, 2024
$6.1M
7,899 prescriptions
Company payments, 2025
$2,885
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jesse Romeu-Velez was code 99213 (office e&m - established), 589 times for 390 patients. In total Jesse Romeu-Velez billed 2,572 services in 39 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 589 | 390 | $61.00 | $36K |
| 94726 Pulmonary Function Testing | Office | 419 | 418 | $38.82 | $16K |
| 94729 Pulmonary Function Testing | Office | 405 | 404 | $39.83 | $16K |
| 99214 Office E&M - Established | Office | 275 | 174 | $90.01 | $25K |
| 94060 Pulmonary Function Testing | Office | 246 | 245 | $26.80 | $6,592 |
| 94010 Pulmonary Function Testing | Office | 174 | 174 | $18.62 | $3,240 |
| 99203 Office E&M - New | Office | 104 | 104 | $74.21 | $7,718 |
| 94729 Pulmonary Function Testing | Facility | 44 | 44 | $6.77 | $298 |
| 71250 CT/CTA - Chest | Office | 40 | 39 | $94.89 | $3,796 |
| 94618 Pulmonary Function Testing | Office | 31 | 30 | $26.15 | $811 |
| 99204 Office E&M - New | Office | 29 | 29 | $116.87 | $3,389 |
| 71271 CT/CTA - Chest | Office | 29 | 29 | $133.05 | $3,858 |
| 94010 Pulmonary Function Testing | Facility | 25 | 25 | $6.27 | $157 |
| 94727 Pulmonary Function Testing | Facility | 23 | 23 | $9.12 | $210 |
| 94060 Pulmonary Function Testing | Facility | 22 | 22 | $7.78 | $171 |
By year: 2022 $179K for 3,313 services; 2023 $163K for 3,064 services; 2024 $126K for 2,572 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 12 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Jesse Romeu-Velez prescribed most often to Medicare patients was Prednisone, with 1,137 prescriptions and refills. In total Jesse Romeu-Velez wrote 7,899 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,137 | 2,921 | 444 | $12K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,035 | 1,886 | 278 | $1.2M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 835 | 1,085 | 339 | $24K |
| Azithromycin Generic | 715 | 1,712 | 268 | $23K |
| Montelukast Sodium Generic | 606 | 1,721 | 204 | $7,321 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 368 | 673 | 121 | $413K |
| Symbicort Budesonide/Formoterol Fumarate | 253 | 560 | 93 | $125K |
| Levocetirizine Dihydrochloride Generic | 236 | 654 | 101 | $4,318 |
| Breo Ellipta Fluticasone/Vilanterol | 219 | 427 | 56 | $168K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 168 | 357 | 57 | $165K |
| Spiriva Respimat Tiotropium Bromide | 156 | 366 | 59 | $188K |
| Adempas Riociguat | 153 | 153 | 16 | $2.0M |
| Isosorbide Dinitrate Generic | 144 | 391 | 50 | $8,880 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 138 | 203 | 27 | $91K |
| Levofloxacin Generic | 107 | 228 | 58 | $1,000 |
Brand drugs: 3,500 claims; generic drugs: 4,399 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesse Romeu-Velez $2,885 ($2,885 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $676.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $676 |
| GlaxoSmithKline, LLC. GSK | 26 | $490 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $229 |
| Lilly USA, LLC LLY | 6 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $190 |
| Insmed, Inc. INSM | 7 | $166 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $153 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $149 |
| Verona Pharma, Inc. VRNA | 6 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.